| Literature DB >> 25337546 |
Jeongseon Kim1, Wook Jin Choi1, Seung Hwa Jeong1.
Abstract
Adverse health outcomes are often seen in breast cancer survivors due to prolonged treatment with side effects such as loss of energy and lack of physical strength. Physical activity (PA) has been proposed as an adequate intervention for women with breast cancer. Therefore, this review summarizes the effects of physical activity on breast cancer survivors after diagnosis. We searched electronic databases including PubMed, Medline, Embase, and Google Scholar for articles published between January 1980 and May 2013. We included a variety of studies such as randomized controlled trials, pilot studies, and clinical trials. We reviewed these studies for three major outcomes: changes in breast cancer mortality, physiological functions, and metabolic biomarkers. Of 127 studies, 33 studies were selected as eligible studies. These studies included physical activities of varying type, duration, frequency, and intensity (e.g., aerobic and resistance training) and examined changes in three major outcomes among breast cancer survivors. Many of the studies suggest that breast cancer survivors benefit from engaging in physical activity, but some studies were limited in their ability to provide adequate evidence due to relatively small sample sizes, short intervention periods, or high attrition. Based on epidemiological evidence, recent studies demonstrated that those breast cancer survivors who engaged in physical activity significantly lowered their risk of breast cancer mortality and improved their physiological and immune functions. Some studies demonstrated changes in metabolic biomarkers such as insulin and insulin-like growth factors. However, further investigation is required to support these findings because these results are not consistent.Entities:
Keywords: Breast cancer; Metabolic biomarker; Mortality; Physical activity; Physiological function
Year: 2013 PMID: 25337546 PMCID: PMC4189463 DOI: 10.15430/jcp.2013.18.3.193
Source DB: PubMed Journal: J Cancer Prev ISSN: 2288-3649
Fig. 1.Flow diagram for selection of eligible studies.
The effects of physical activity on breast cancer mortality risk
| Author (yr) | Study design (yr) | N | Follow-up (yr) | Age (mean) | PA type | MET (hr/wk) | Mortality (HR/RR; 95% CI) |
|---|---|---|---|---|---|---|---|
| Holmes et al. | NHS (1984–1998) | 2,987 | 8 | 42.5 |
Choice of 8 Activities
- Walking outdoors - Jogging (>10 min/mi) - Running (≤10 min/mi) - Bicycling (stationary) - Swimming laps - Tennis - Aerobics - Squash/racquetball | <3 (reference)
3–8.9 9.0–14.9 15.0–23.9 ≥24.0; | RR (Ptrend<0.004)
0.80; 0.60–1.06 0.50; 0.31–0.82 0.56; 0.38–0.84 0.60; 0.40–0.89 |
| Holick et al. | CWLS (1988–2001) | 4,482 | 5.6 | 54 |
Recreational PA
- Walking outdoors - Running (≥10 min/mi) - Lap swimming - Sports - Calisthenics - Aerobic recreation | <2.8 (reference)
2.8–7.9 8.0–20.9 ≥21.0; | HR (Ptrend=0.050)
0.66; 0.39–1.13 0.61; 0.36–1.05 0.49; 0.27–0.89; |
| Irwin et al. | HEAL (1995–1998) | 933 | 6 | 55 |
All types of PA
- Recreational - Occupational - Household | 0 (reference)
>0–8.9 ≥9 | HR (Ptrend=0.460)
0.72; 0.28–1.85 0.65; 0.23–1.87 |
| Sternfeld et al. | LACE (1997–2000) | 1,970 | 7.25 | 48.5 |
PA questionnaire
- Occupational - Non-work routine - Recreational - Transportation | <29 (reference)
29≤44 44≤62 ≥62 | HR (Ptrend=0.410)
1.01; 0.57–1.78 0.70; 0.38–1.29 0.87; 0.48–1.59 |
| Bertram et al. | WHEL (1995–2000) | 2,361 | 7.1 | 48 |
Meeting PA guidelines | No→no (reference)
No→yes Yes→no Yes→yes | HR
1.44; 1.02–2.03 (Ptrend=0.040) 1.22; 0.81–1.83 (Ptrend=0.340) 0.93; 0.70–1.24 (Ptrend=0.620) |
| Irwin et al. | WHI (1993–1998) | 4,643 | 3/6 | 63.6 |
Walking Recreational PA | 0 (reference)
>0–3 3.1–8.9 9+ | HR (Ptrend=0.049)
0.30; 0.09–0.99 0.77; 0.43–1.38 0.61; 0.35–0.99 |
| Chen et al. | SBCSS (2002–2006) | 4,826 | 4.3 | 53.5 |
Walking (52%) Gymnastics (14%) Body building (7%) Qigong/Tai Chi (5%) | 0 (reference)
6 month (8.3 MET) 18 month (15.4 MET) 36 month (15.8 MET) | HR (Ptrend=0.050)
0.91; 0.75–1.11 0.71; 0.57–0.90 0.60; 0.47–0.76 |
| Beasley et al. | ABCPP (pooling project) | 13,302 | 1.9 | 50 |
2008 PA guidelines at least 2.5-h (10 MET-h/week) | <10 (reference) | HR: |
NHS, the nurses’ health study; CWLS, the collaborative women’s longevity study; HEAL, the health, eating, activity, and lifestyle study; LACE, the life after cancer epidemiology study; WHEL, the women’s healthy eating and living study; WHI, the women’s health initiative; SBCSS, the shanghai breast cancer survival study; ABCPP, the after breast cancer pooling project.
The effects of physical activity on physiological functions
| Author (yr) | Follow-up/Total N | Age (Mean±SD) | Duration (wk) | Intervention (frequency/wk) | Key outcome (P<0.05) |
|---|---|---|---|---|---|
| Segal et al. | 99/123 | 50.9 (8.7) | 26 |
Self-directed/home-based (5×) Supervised
- Fitness center (3×) - Home-based (2×) |
No significant differences in aerobic capacity (VO2 max) |
| Burnham et al. | 18/18 | 53.6 (8.6) | 10 |
Supervised (3×)
- Treadmill walking - Stationary bicycles - Stair-climbing machines; |
VO2 max↑ (P<0.001) Flexibility: Sit and reach (cm)↑ (P<0.002) |
| Courneya et al. | 50/53 | 59 (6) | 15 |
Cycle ergometers (3×) |
VO2 peak↑ (P<0.001) |
| Pinto et al. | 21/24 | 52.5 (6.8) | 12 |
Supervised cardiovascular fitness (3×)
- Treadmill walking - Arm and leg ergometers - Arm cycling - Stationary cycling - Rowing |
Peak SBP↓ (P≤0.050) SBP, DBP, HR at 75 W↓ (P≤0.010; P<0.050; P<0.050) |
| Thorsen et al. | 111/139 | 39.1 (8.4) | 14 |
Supervised and home-based flexibility training
- Walking - Muscle-strengthening (>2×; >30 min) |
VO2 max↑ (P<0.010) |
| Sprod et al. | 8/12 | 54.7 (3.6) | 8 |
Supervised walking stick (2×; 1×20 min) |
Shoulder function↑
- Bench press↑ (P=0.046) - Lat pull down↑ (P=0.013) |
| Cho et al. | 55/65 | 49.1 (7.7) | 10 |
Group and home-based
- Aerobic activity - Stretching (2×; 1×90 min) |
Shoulder of joint↑
- Extension↑ (P=0.000) - Abduction↑ (P=0.011) - External/internal rotation ↑ (P=0.006; P=0.000) |
| Kim et al. | 41/74 | 51.3 (6.7) | 8 |
Supervised (3×)
- Walking - Cycling - Jogging - Treadmill running |
VO2 peak↑ (P=0.000) HRR↓ (P=0.030) SBP resting↓ (P=0.040) SBP maximum↓ (P=0.020) |
| Battaglini et al. | 20/20 | 57 (19.5) | 21 |
Supervised cardiovascular, resistance, flexibility training (2×; 1×<60 min) |
Overall muscle strength↑ (P=0.025) |
| Rogers et al. | 39/41 | 53 (9) | 12 |
The BEAT cancer program (1-3× supervised, 2, 3, or 5×home-based) |
Left-handed grip↑ (P=0.030) Back/leg muscle extensor strength↑ (P=0.017) |
| Schmitz et al. | 139/141 | 56.5 (8.5) | 48 |
Weight lifting (2×; 1×90 min) |
Upper and lower-body strength↑ (P<0.001) |
| Twiss et al. | 209/223 | 58.7 (7.5) | 96 |
Weight training (2×; 30–45 min) |
Hip flexion↑ (P=0.011) Hip extension↑ (P=0.000) Knee flexion↑ (P<0.000) Knee extension↑ (P=0.001) Wrist flexion↑ (P=0.031) Balance↑ (P=0.010) |
| LaStayo et al. | 40/49 | 74 (6) | 12 |
The RENEW exercise (3×)
- Eccentric stepper |
Muscle size↑ (P=0.001) |
| Kalsatou et al. | 27/27 | 56.8 (4.2) | 24 |
Traditional Greek dance (3×; 1×60 min) |
Right and left handed-grip strength↑ (P=0.001) Left-arm volume↓ (P=0.028) |
| Brdareski et al. | 18/18 | 52.1 (7.4) | 3 |
Bicycle ergometers (2×) |
VO2 max↑ (P<0.002) % VO2 max↑ (P<0.002) |
VO2 max, maximum oxygen uptake; VO2 peak, peak oxygen consumption; HR, heart rate; HRR, heart rate at resting; SBP, systolic blood pressure; DBP, diastolic blood pressure; BEAT, the better exercise adherence after treatment for cancer; RENEW, the resistance exercise via negative eccentrically-induced work.
The effects of physical activity on metabolic biomarkers
| Author (yr) | Follow-up/Total N | Age (Mean±SD) | Duration (wk) | Intervention (Frequency/wk) | Key outcome (P<0.05) |
|---|---|---|---|---|---|
| Nieman et al. | 12/16 | 53.5 (-) | 8 |
Supervised aerobic and weight training (3×; 1×60 min) |
No significant changes in NKCA |
| Peters et al. | 24/24 | 49.3 (6.4) | 28 |
Bicycle training (5×; 1×30–40 min) |
% of lymphocytes↓ (P<0.050) % granulocytes↑ (P<0.050) Resting level of monocytes↓ (P<0.050) Phagocytosis (%, PI) vs. RDSE↑ (P<0.050) |
| Fairey et al. | 52/53 | 59 (6) | 15 |
Cycle ergometers (3×) |
IGF-1↓ (P=0.045) IGFBP-3↑ (P=0.021) |
| Fairey et al. | 52/53 | 59 (6) | 15 |
Cycle ergometers (3×) |
NKCA↑
- Total lytic units (P=0.035) Lymphocyte proliferation↑ (Spontaneous [3H]thymidine) (P=0.007) |
| Fairey et al. | 52/53 | 59 (6) | 15 |
Cycle ergometers (3×) |
No significant changes in CRP (P=0.060) |
| Hutnick et al. | 36/49 | 48.5 (10.6) | 24 |
Trainer with 1:1 session
- Aerobic activity - Stretching (3×; 1×40–90 min) |
% CD4+CD69+↑ (P=0.050) Level of tritiated thymidine ↑ (counts/min P=0.050) |
| Schmitz et al. | 69/85 | 53 (8.1) | 24 |
Weight training (2×) |
GF-II↓ (P=0.020) |
| Ligibel et al. | 82/101 | 52.5 (9) | 16 |
Strength training (2×; 1×50 min) Home-based (1×90 min) |
Insulin-resistance↑ (P=0.050) Insulin↓ (P=0.070) Glucose HOMA↓ (P=0.090) |
| Irwin et al. | 68/75 | 56 (8.6) | 24 |
Supervised aerobic training at local health club (3×) Home-based (2×) |
Insulin IGF-1↓ (P=0.026) IGFBP-3↓ (P=0.006) |
| Janelsins et al. | 19/31 | 53 (8.6) | 12 |
TCC (3×; 1×60 min) |
IGF-1 (−) IGFBP-1 (P=0.001) IGF-1 (+) IFN-γ (P=0.024) IFN-γ (+) Insulin (P=0.055) |
NKCA, NK cell cytotoxic activity; PI, phagocytotic index; RDSE, receptor destroying enzyme-treated sheep erythrocytes; IGF-1, IGF-II, insulin-like growth factor-I, II; IGFBP-1, 3, insulin-like growth factor biding protein-1, 3; CRP, C-reactive protein; HOMA, the homeostatic assessment model; TCC, Tai Chi Chuan; IFN-γ, Interferon-gamma;
, no changes; (−), negative/inverse correlation; (+), positive correlation.